Covered recipient · General Payments record
HACK J KIM
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2023
$1,068.54
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $166.09 | 8 |
| Education | $22.16 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $64.30 | 2 |
| ABBVIE INC. | $33.46 | 2 |
| Janssen Biotech, Inc. | $25.31 | 1 |
| Ardelyx, Inc. | $21.23 | 1 |
| Celgene Corporation | $15.19 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.82 | 1 |
| Gilead Sciences, Inc. | $13.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.96 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997649131 | CMS |
| ABBVIE INC. | $13.50 | 09/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997649133 | CMS |
| Ardelyx, Inc. | $21.23 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052951531 | CMS |
| Celgene Corporation | $15.19 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015530013 | CMS |
| Gilead Sciences, Inc. | $13.94 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026023617 | CMS |
| Janssen Biotech, Inc. | $25.31 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988166793 | CMS |
| Regeneron Healthcare Solutions, Inc. | $22.16 | 05/11/2023 | Education | Undisputed | 01/23/2026 | 999249965 | CMS |
| Regeneron Healthcare Solutions, Inc. | $42.14 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999249969 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.82 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057489729 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.